Clinical Trial Update: Treatment With Zoledronic Acid in Patients With Breast Cancer, Multiple Myeloma, and Prostate Cancer With Cancer Related Bone Lesions [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating zoledronic acid in patients with breast cancer, multiple myeloma, and prostate cancer with cancer-related bone lesions has c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Multiple Myeloma
• Prostate Cancer

Drugs mentioned

• Zoledronic acid (Zoledronic acid)

Snippet

Sponsor: Novartis | Conditions: Breast Cancer, Multiple Myeloma | Phase 4 | Status: COMPLETED